VPIM
KRYS icon

Vanguard Personalized Indexing Management’s Krystal Biotech KRYS Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$782K Buy
3,027
+900
+42% +$239K 0.01% 1053
2025
Q4 		$524K Buy
2,127
+116
+6% +$24.4K 0.01% 1231
2025
Q3 		$355K Buy
2,011
+316
+19% +$47.3K ﹤0.01% 1411
2025
Q2 		$233K Sell
1,695
-251
-13% -$36.9K ﹤0.01% 1555
2025
Q1 		$351K Buy
1,946
+546
+39% +$91.8K 0.01% 1272
2024
Q4 		$219K Sell
1,400
-138
-9% -$24.5K ﹤0.01% 1486
2024
Q3 		$280K Buy
1,538
+164
+12% +$31.6K ﹤0.01% 1375
2024
Q2 		$252K Buy
+1,374
New +$231K ﹤0.01% 1345

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return